B · Normal
[Innovative drug concepts are active, Zhaoyan New Drug is approaching the daily limit] On October 20, innovative drug concepts are active, Zhaoyan New Drug is approaching the daily limit, Sanli Pharmaceutical, CSPC Innovation, Heyuan Biotech, Chengda Pharmaceutical, and Sansheng Guojian are following the rise. On the news, the National Development and Reform Commission held a press conference in October. Zuo Gang, deputy director of the National Economic Comprehensive Department of the National Development and Reform Commission, said that in the first three quarters, the foreign technology authorization of innovative drugs amounted to approximately US$130 billion, which was close to the whole of last year.
Live broadcast 🕐 2026-10-20 10:46
#Live broadcast #Innovative drugs
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Analysis of the midday limit on October 20] According to news on October 20, a 10-20 11:50 [Afternoon Commentary: The Science and Technology Innovation 50 Index rose 0.79% 10-20 11:31 [The food and beverage sector moved up unexpectedly, Anji Food rose by the daily 10-20 11:25 [Main Fund Monitoring: Ningde Times’ net sales exceeded 800 million] On October 10-20 10:55 [The rise of the device-side AI concept expands, and Hengxuan Technology and oth 10-20 10:52 [The folding screen concept fluctuated and surged, and Jingyan Technology rose b 10-20 10:46

Comments

0/500
Captcha (click to refresh)
No comments yet